tradingkey.logo
tradingkey.logo
Search

Alcresta Therapeutics Announces Enrollment Of First Patient In Clinical Trial Evaluating Use Of Relizorb

ReutersApr 29, 2025 12:27 PM
facebooktwitterlinkedin

-

  • ALCRESTA THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN CLINICAL TRIAL EVALUATING USE OF RELIZORB IN PANCREATITIS PATIENTS AT MASSACHUSETTS GENERAL HOSPITAL

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI